SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-031112
Filing Date
2024-03-05
Accepted
2024-03-05 17:55:31
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248017d8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm248017d8_4seq1.xml 4 4594
  Complete submission text file 0001104659-24-031112.txt   6415
Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Maynard Ryan D (Reporting) CIK: 0001363984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 24722860

Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)